XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Fair value measurement (Tables)
9 Months Ended
Sep. 30, 2021
Fair value measurement  
Schedule of assets and liabilities measured at fair value on recurring basis

 

Quoted prices
in active
markets
(Level 1)

 

Significant
other
observable
inputs
(Level 2)

 

Significant
unobservable
inputs
(Level 3)

 

Total

 

Classification in Consolidated
balance sheets

(in thousands)

At December 31, 2020

Assets:

Cash, cash equivalents and restricted cash

$

247,680

$

$

$

247,680

Cash and cash equivalents; other non-current assets

Total assets

$

247,680

$

$

$

247,680

Liabilities:

Derivative financial instruments

2,645

2,645

Other non-current liabilities

Total liabilities

$

$

$

2,645

$

2,645

At September 30, 2021

Assets:

Cash, cash equivalents and restricted cash

$

581,270

$

$

$

581,270

Cash and cash equivalents; other non-current assets

Total assets

$

581,270

$

$

$

581,270

Liabilities:

Contingent consideration

23,781

23,781

Contingent consideration

Derivative financial instruments

2,645

2,645

Other non-current liabilities

Consideration for post-acquisition services

280

280

Other non-current liabilities

Total liabilities

$

$

$

26,706

$

26,706

Schedule of changes in fair value of contingent consideration

Amount of

contingent

consideration

2021

(in thousands)

Amount recorded on Acquisition Date

$

23,950

Change in fair value (included within research and development expenses)

416

Currency translation effects

(585)

Balance at September 30, 2021

$

23,781